Comorbidities frequently accompany chronic heart failure, contributing to increased morbidity and mortality, and an impaired quality of life. Extreme comorbidity is significantly more common in patients with chronic heart failure due to left ventricular systolic dysfunction. The efficient management of such complexity requires the integration of general and specialist expertise.
Pharmacy Challenges in Cardiac Care During COVID-19: Lessons Learnt
02 February 2023
Cardiac Failure Review 2023;9:e03.
Ranolazine to Improve Diastolic Performance
21 January 2023
European Cardiology Review 2023;18:e02.
Polypharmacy in Older People With Heart Failure
19 December 2022
Cardiac Failure Review 2022;8:e34.
SGLT2i in HFpEF
08 July 2022
Cardiac Failure Review 2022;8:e26.